Last reviewed · How we verify

NCT05917899: LEP vFCR

Limited English Proficiency Virtual Family-Centered Rounds

Completed NA Last updated 25 November 2024
What this trial tests

NA trial testing Virtual Family-Centered Rounds in Pediatric Disorder in 36 participants. Completed in 14 June 2024.

Timeline
10 August 2023
Primary endpoint
14 June 2024
14 June 2024

Quick facts

Lead sponsorUniversity of California, Davis
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment36
Start date10 August 2023
Primary completion14 June 2024
Estimated completion14 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Davis

Who can join

Eligibility, any sex, with Pediatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a pilot test of using telehealth with an interpreter as an additional option for parents with limited English proficiency to join family-centered rounds in the neonatal intensive care unit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Protocol for a single-arm feasibility trial of virtual family-centered rounds: increasing opportunities for family engagement among caregivers with language preference other than English.
    Hoyt-Austin AE, Zerda EN, Tancredi DJ, Marcin JP, et al · · 2025 · cited 1× · PMID 39940014 · DOI 10.1186/s40814-025-01599-4

Verify or expand the search:

Other recruiting trials for Pediatric Disorder

Currently open trials in the same condition.

Other University of California, Davis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing